Botox might help treat bladder disorders

May 19, 2014 by Maureen Salamon, Healthday Reporter
Botox might help treat bladder disorders
Studies found it eased incontinence, helped counter loss of bladder control.

(HealthDay)—Many still think of Botox as a wrinkle smoother, but new research shows the toxin's growing list of medical uses now includes the treatment of two common causes of urinary frequency, urgency and incontinence.

Scientists have found that Botox (botulinum toxin A)—the same toxin that causes the life-threatening type of food poisoning known as botulism—may be used in place of surgery or other invasive treatments for stubborn cases of conditions causing control problems.

"We think Botox has two different kinds of effects in the bladder. One, it blocks the nerve endings that go to the muscles that are responsible for bladder contractions," said urologist Dr. Rose Khavari, director of research at the Houston Methodist Center for Restorative Pelvic Medicine, who wasn't involved in the new research.

"The other way we think it works ... is by blocking the sensory effect, the sensation of frequency and urgency from the brain," she added. "So it helps with patients who don't have incontinence, but have bothersome frequency and urgency."

The two studies are scheduled for presentation Saturday at the American Urological Association's annual meeting in Orlando, Fla. Research presented at scientific conferences typically has not been peer-reviewed or published and results are considered preliminary.

In recent years, Botox has been found useful for many medical conditions, including chronic migraines, severe muscle spasms, excessive underarm sweating and misaligned eyes, according to the U.S. National Library of Medicine. The type of Botox used for problems is the same as that used for wrinkle smoothing, Khavari explained, only delivered in lower strengths and larger amounts.

The first study, funded by the Taiwanese government, compared the delivery of Botox treatment to overactive bladder patients through either 20 to 30 needle injections or one infusion directly into the bladder with a catheter. The patients had tried and failed drug therapy for the condition, which can lead to incontinence from involuntary contractions of the .

Four weeks later, the single Botox infusion (compared to a placebo) had significantly reduced participants' urinary frequency and urgency, with no increase in the volume of urine left in the bladder after urinating. For many patients, one infusion would be preferable to dozens of injections, said study author Dr. Michael Chancellor, director of neuro-urology at Oakland University-William Beaumont School of Medicine in Michigan.

"The idea is that patients don't feel the urge to pee so much, but [Botox] doesn't paralyze the muscles so we don't have the risk of retaining urine," Chancellor said. "It's great that [Botox treatment] worked, but the key thing is it removed the side effects, which is muscle paralysis."

The second study examined Botox use in so-called neurogenic bladder, a condition causing lack of bladder control due to a brain, spinal cord or nerve condition. Symptoms depend on the cause but often include incontinence.

University of Kansas researchers reviewed medical charts from patients seen in their medical practice between 2003 and 2013 with drug-resistant neurogenic bladder who underwent surgery to either enlarge their bladder or remove it, diverting urine into an external bag.

Since Botox was approved by the U.S. Food and Drug Administration in 2011 for neurogenic bladder, the proportion of patients for whom it might have replaced invasive surgery was analyzed. (Some had received treatment after the FDA decision.)

Of 59 patients, 34 underwent bladder surgery and 25 were treated with Botox, researchers found. But 62 percent of the 34 patients who underwent surgery would have been eligible for Botox instead, and use of the toxin potentially could have cut the number of bladder surgeries done annually by half.

Khavari said she and her colleagues used Botox off-label for neurogenic bladder patients before the 2011 FDA approval. The results of this research confirm "what we already know and experience in our own practice," she said.

"For a lot of these , it has totally changed the way they manage their life," she said. "They feel like they are in control instead of their bladder being in control."

Explore further: US approves Botox for bladder control

More information: The U.S. National Library of Medicine has more information on the medical uses for Botox.

Related Stories

US approves Botox for bladder control

August 24, 2011
The face-freezing pharmaceutical injection Botox gained another medical use on Wednesday when the US government approved it for use in some patients with overactive bladder.

FDA gives nod to botox to treat overactive bladder

January 19, 2013
(HealthDay)—The U.S. Food and Drug Administration on Friday gave its approval for the use of Botox against a form of urinary incontinence known as overactive bladder.

Botox offers hope to women with incontinence

January 29, 2013
When most people hear Botox, they think of injections to the face to combat wrinkles and aging.

Botox now used for urinary incontinence

March 14, 2012
When you think of Botox injections, you probably think of getting rid of unwanted wrinkles around the eyes or forehead, but recently the U.S. Food and Drug Administration (FDA) approved using the injections to help patients ...

FDA approves Botox for crow's feet

September 11, 2013
If you have a high school reunion coming up, here's a medical development that you may want to keep an eye on.

Botox shows promise against persistent neck, shoulder pain

October 14, 2012
(HealthDay)—Botox injections, long used to smooth away wrinkles, might also soothe chronic neck and shoulder muscle pain, new research suggests.

Recommended for you

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.